Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04871932
Other study ID # COVID-2019-VIR-SCMO study
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date February 1, 2021
Est. completion date December 3, 2026

Study information

Verified date May 2021
Source RenJi Hospital
Contact Jun Pu, MD,PhD
Phone 86-21-68383477
Email pujun310@hotmail.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

In recent years, single-cell high-throughput sequencing technology has developed rapidly and is widely used in research related to the immune system, breaking traditional cognition and gaining a new understanding of immune cell classification. In particular, the emerging single cell RNA sequencing (scRNA-seq) provides new ideas for the study of cell heterogeneity in multicellular organisms. Analyzing the changes in the expression profile of the cell transcriptome at the single-cell level can clearly show the changes in the trajectory of individual cells, reveal new cell types, and discover the potential functions of immune cells. Therefore, this study intends to recruit healthy adults and use multi-omics techniques such as single-cell sequencing to systematically classify the peripheral blood mononuclear cells of healthy adults to provide a basis for further disease-related research.


Description:

As an important part of the human body, the immune system is closely related to the occurrence of diseases. Based on the traditional classification methodology, it is mainly divided into two branches: innate immunity and adaptive immunity. Innate immune cells mainly include monocytes (Mono), natural killer (NK) cells and dendritic cells (DC). The adaptive immune cells mainly include B lymphocytes (B) and T lymphocytes (T). Peripheral blood mononuclear cells (PBMCs) mainly include T cells, B cells, NK cells, Mono cells and DC cells. The proportion of these cell populations varies among individuals. Usually in PBMC, T lymphocytes account for 45-70%, B cells account for 5-15%, NK cells account for 5-20%, Mono cells account for 10-30%, and DC cells account for 1-2%. Among them, B cells can be divided into transitional, naive, memory subgroups and plasma cells. While, T cells are mainly composed of cluster of differentiation 4+ (CD4+) T cells and cluster of differentiation 8+ (CD8+) T cells with the ratio about 2:1. What's more, CD4+ T cells and CD8+ T cells can be further divided into naive cells, central memory cells in contact with antigen, effector memory cells and effector cells. Mono cells can be divided into classic monocytes and non-classical cluster of differentiation 16+ (CD16+) pro-inflammatory monocytes. DC cells include plasmacytic dendritic cells (pDC) and myeloid dendritic cells (mDC). In recent years, scRNA-seq has developed rapidly and is widely used in research related to the immune system, breaking traditional cognition and gaining a new understanding of immune cell classification. In particular, the emerging scRNA-seq provides new ideas for the study of cell heterogeneity in multicellular organisms. Analyzing the changes in the expression profile of the cell transcriptome at the single-cell level can clearly show the changes in the trajectory of individual cells, reveal new cell types, and discover the potential functions of immune cells. Adults have a relatively stable immune system, with little interference from the external environment. Therefore, this study intends to recruit healthy adults and use multi-omics techniques such as scRNA-seq to systematically classify the PBMCs of healthy adults to provide a basis for further disease-related research.


Recruitment information / eligibility

Status Recruiting
Enrollment 50
Est. completion date December 3, 2026
Est. primary completion date November 3, 2026
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 50 Years
Eligibility Inclusion Criteria: 1. Age from 18 to 50 years; 2. No history of major diseases, no history of bacterial or viral infection in the past 3 months; 3. No recent history of surgery or trauma; 4 No history of smoking or alcoholism; 5. No immune system disease. Exclusion Criteria: 1. Infectious diseases; 2. Tumor diseases; 3. Hematological diseases; 4. History of hypertension and diabetes; 5 Autoimmune diseases; 6 History of liver and kidney insufficiency; 7. History of previous cardiovascular diseases; 8. Pregnancy Or breast-feeding; 9. Past and current use of immunosuppressive drugs

Study Design


Related Conditions & MeSH terms

  • Immune System and Related Disorders

Intervention

Biological:
Recently Vaccination


Locations

Country Name City State
China Cardiology, Ren Ji Hospital Shanghai

Sponsors (1)

Lead Sponsor Collaborator
RenJi Hospital

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Changes in classification of human peripheral blood mononuclear cells The primary endpoint will be the changes in classification of human peripheral blood mononuclear cells at single cell resolution. up to five years
See also
  Status Clinical Trial Phase
Completed NCT02807623 - Do NSAIDS or Executing Exercise Decrease Local Erythema, Site Swelling & Pain After INoculation N/A
Active, not recruiting NCT00663676 - Growth Hormone Administration and the Human Immune System - I Phase 0
Completed NCT04498208 - Immune Modulation by Enhanced vs Standard Prehabilitation Program Before Major Surgery N/A
Terminated NCT02296359 - Vaccination Response in Individual Monozygotic Twins N/A
Completed NCT03288831 - Changes in Intestinal Permeability 4 Hours After Gluten Challenge N/A
Terminated NCT02654704 - Vaccination Responses in Young and Older Adults
Not yet recruiting NCT06051461 - Deciphering the Role of Dietary Fatty Acids on Extracellular Vesicles-mediated Intercellular Communication N/A
Recruiting NCT06390696 - Sand Play - the Effect of Biodiversity Exposure on Atopic Dermatitis N/A
Completed NCT06286839 - Study of Cannabidiol (CBD) in Healthy Volunteers N/A
Not yet recruiting NCT04707365 - Microenvironment and Immunity of Digestive Cancers - East Paris Multicentric Cohort N/A
Completed NCT05174624 - The Healthy Human Global Project - Hong Kong (HHGP-Hong Kong)
Completed NCT06129578 - Plant Protein Supplementation Within a Healthy Lifestyle Modulates Plasma Circulating Amino Acids and Improves the Health Status of Overweight Individuals N/A
Recruiting NCT03925272 - Creation of a Prospective Cohort of Healthy and Sick Subjects and of a Collection of Associated Biological Resources, for the Study of the Immune System and of Its Genetic and Environmental Determinants. N/A
Completed NCT04757987 - An Observational Study of Distress, Immune Function, and Pain in HIV.
Active, not recruiting NCT06390683 - Biodiversity Interventions for Assisted Living Centers N/A
Active, not recruiting NCT05746013 - Lipoproteins and ImmunoMetabolism N/A
Active, not recruiting NCT03963700 - Tumor Characteristics in Patients With Paraneoplastic Neurological Syndromes (PNS)
Recruiting NCT05299112 - An Exploratory Study of Increased Preterm Arginine INTake (PAINT18) N/A
Completed NCT03492086 - Study of the Consumption of a Food Supplement in a Group of Healthy People N/A
Recruiting NCT05306925 - An Exploratory Study of Arginine Supplementation and the Postoperative Immune REsponse N/A